Save time and get answers to complex questions with AI chat
Patent expiration date of guselkumab?What is the difference between apixaban and apixaban accord?Dabrafenib btd date 2023?Zemdri nce gain exclusivity 2028 patent 2031?What's the advised delay for milk post lipitor?
See the DrugPatentWatch profile for Ubrogepant
Ubrogepant (brand name Ubrelvy) received its first FDA approval on December 23, 2019. [1]
Most searches for “ubrogepant approval date” refer to the first FDA approval date for Ubrelvy. That date is December 23, 2019. [1]
Approval dates can differ by country and by whether you mean the first approval versus later regulatory actions. For the FDA (U.S.), the first approval date is December 23, 2019. [1]
The approval on December 23, 2019 was for Ubrelvy (ubrogepant), used for the acute treatment of migraine. [1] Sources [1] https://www.drugs.com/history/ubrogepant.html
Other Questions About Ubrogepant :